Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03802149 · ClinicalTrials.gov registry record · Early Phase 1
Ulipristal Acetate for Cervical Preparation
A Early Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 13
- Enrollment target
NCT03802149: Completed Early Phase 1 study, sponsored by Stanford University.
NCT03802149 is a Early Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03802149, a Early Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
This is a prospective cohort study exploring a broadened use of ulipristal acetate as a cervical preparation agent for second trimester surgical abortion. Specifically, this pilot study will test the feasibility of using ulipristal as a pharmacologic cervical preparation with adjunct misoprostol prior to surgical abortion.
Interventions
- DRUG Ulipristal Acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-04-16 |
| Est. Completion | 2020-04-02 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03802149
The ClinicalTrials.gov registry entry for NCT03802149 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ulipristal Acetate is the first listed.
NCT03802149 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03802149 about?
NCT03802149 is a clinical study titled "Ulipristal Acetate for Cervical Preparation". This is a prospective cohort study exploring a broadened use of ulipristal acetate as a cervical preparation agent for second trimester surgical abortion. Specifically, this pilot study will test the feasibility of using ulipristal as a pharmacologic cervical preparation with adjunct misoprostol pri...
What is the current status of trial NCT03802149?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 13 participants. The study started on 2019-04-16. Estimated completion is 2020-04-02.
What interventions are being tested in trial NCT03802149?
The interventions under investigation include: Ulipristal Acetate (DRUG).
Who is sponsoring clinical trial NCT03802149?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.